Osseointegration for Lower and Upper Limbs — CPB 1045 | AETNA Coverage Update

Aetna modified CPB 1045 governing osseointegration surgery for upper and lower limbs, effective January 22, 2026. Osseointegration remains experimental and non-covered — but the updated documentation and Standard Written Order requirements now add new claim denial risk for any supplier billing HCPCS L5991.

Aetna, a CVS Health company, updated Clinical Policy Bulletin CPB 1045 to sharpen the documentation rules around osseointegration surgery and osseoanchored prostheses. The core coverage position hasn't changed — Aetna still classifies osseointegration surgery as experimental, investigational, or unproven. What has changed is the specificity around what documentation will and won't hold up if a claim is submitted. If your billing team processes any claims touching L5991, Z47.81, or Z89.9, you need to read the updated Standard Written Order (SWO) requirements now.

Quick-Reference Table

Aetna Osseointegration Coverage Criteria and Medical Necessity Requirements 2026

The Aetna osseointegration coverage policy is blunt: osseointegration surgery is experimental. That applies to the procedure itself, the prosthesis, the OPRA Implant System (Osseoanchored Prostheses for the Rehabilitation of Amputees), and the Axor II connection device. Aetna's position is that effectiveness has not been established. There are no coverage criteria that unlock reimbursement for this surgery — because the surgery isn't covered at all.

This matters for your billing team in a specific way. If a patient pursues osseointegration and expects their Aetna plan to cover it, the claim will be denied. No amount of documentation makes the procedure covered. But documentation failures create a second layer of exposure — they can turn a clean experimental denial into a messy fraud and abuse situation if records look inconsistent or incomplete.

The updated CPB 1045 Aetna system now embeds DME MAC policy language directly into the coverage bulletin. That's the real change. Aetna is aligning its documentation standards with Medicare Administrative Contractor rules for durable medical equipment. If you bill DME to Medicare patients and already follow MAC documentation standards, this will feel familiar. If you don't, January 22, 2026 is your wake-up call.

Medical necessity documentation rules under the updated policy:

That last point is sharper than it looks. If a DME supplier prepares the documentation and also has a financial stake in the device, Aetna won't treat that paperwork as sufficient. You need independent medical record support. Full stop.

Aetna Osseointegration Exclusions and Non-Covered Indications

The blanket experimental classification covers osseointegration surgery and prostheses for limb loss. That includes any system — OPRA, Axor II, or otherwise — marketed for amputee rehabilitation through bone-anchored prosthetic attachment.

There is one important carve-out. This coverage policy does not apply to osseointegrated devices for auditory applications — specifically brainstem auditory devices, osseointegrated implants to the mastoid process of the temporal bone, and auditory brainstem devices. Those are addressed separately and are not classified as experimental under CPB 1045. If your practice bills for auditory osseointegration, this policy doesn't govern your claims.

For limb loss specifically, the experimental classification is firm. Prior authorization won't unlock coverage here. You can submit all the documentation in the world — if osseointegration surgery is the procedure, Aetna's answer is no. The billing team's job is to make sure patients understand this upfront and that no one submits a claim expecting a different outcome.

Coverage Indications at a Glance

Aetna Osseointegration Billing Guidelines and Action Items 2026

The experimental designation means your primary job isn't optimizing reimbursement — it's avoiding unnecessary denials and protecting your practice from documentation problems. Here's what to do now.

1. Audit your SWO process against the new CPB 1045 checklist before January 22, 2026.

Every Standard Written Order for L5991 must include all of the following: member name or ID number, order date, general description of the item (HCPCS code, narrative, or brand/model number), each separately billed option or accessory listed individually, HCPCS code and quantity for each item, treating practitioner name and NPI, and treating practitioner signature. If any element is missing, Aetna will deny the claim as not medically necessary. This isn't a technicality — it's the explicit stated consequence in the updated policy.

2. Confirm the ordering provider qualifies as a "treating practitioner" under Aetna's definition.

Under the updated osseointegration billing guidelines, only an MD, DO, PA, NP, or CNS can sign an SWO that Aetna will honor. If your workflow routes SWO signatures through a prosthetist or physical therapist, you have a problem. Fix the workflow before you bill.

3. Do not rely on supplier-prepared statements or attestations as standalone medical necessity documentation.

This is the rule that catches teams off guard. A physician signing a supplier's form isn't enough. You need independent clinical documentation in the medical record that supports medical necessity — and that documentation needs to corroborate whatever is on any form. Aetna's updated policy is explicit: forms are subject to corroboration with the medical record.

4. Flag any documentation prepared by parties with a financial interest in the claim.

If a DME supplier prepares the supporting documentation and also stands to be paid for the device, Aetna won't treat that documentation as sufficient on its own. You need independent medical record support. Build this check into your pre-submission review process.

5. Issue advance beneficiary notices or equivalent patient notifications for all osseointegration procedures.

Because osseointegration surgery is classified experimental, patients with Aetna coverage should be informed in writing before the procedure that their plan won't cover it. This protects your practice and sets accurate financial expectations. Don't wait until after the denial to have that conversation.

6. Cross-reference CPB 0578 (Lower Limb Prostheses) for any related billing.

Aetna's CPB 1045 cross-references CPB 0578, which governs lower limb prostheses. If your team bills for prosthetic components alongside L5991, review CPB 0578 to make sure the covered prosthetic components are documented and coded separately — and that the osseointegration-specific items aren't contaminating an otherwise billable prosthetics claim.

If you're not sure how your current SWO workflow maps to the new checklist, loop in your billing consultant or compliance officer before the effective date.

CPT, HCPCS, and ICD-10 Codes for Osseointegration Under CPB 1045

HCPCS Codes — Non-Covered / Experimental Under CPB 1045

Key ICD-10-CM Diagnosis Codes

A note on L5991: This is the only HCPCS code specifically addressed in CPB 1045, and it covers only the lower extremity connector. There is no specific code listed in the policy for upper extremity osseointegration components. If your team bills for upper limb osseointegration, the policy's experimental classification still applies — but there is no specific HCPCS code assigned under this bulletin. Document the absence of a specific upper extremity code in your internal coding notes.

The policy's reference to "no specific code" for osseointegration/osseoanchored prostheses as a category is also meaningful for osseointegration billing. It signals that Aetna has not established a reimbursement pathway for these procedures — which is consistent with the experimental classification.